StockData
EyePoint, Inc. logo

EyePoint, Inc. (EYPT) stock

EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.30−0.01 (-3.80%)

Close on Nov 17, 2026Market cap $25.51MP/E –Yield –

EyePoint cash

Cash and short-term investments held at the end of each period.

EyePoint's cash was $180.50M at Jun 30, 2026. For fiscal 2025 it was $306.10M, down 17.5% from the year before. Over ten years it grew 32.6% a year on average. The highest annual figure on record is $370.90M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$306.10M-17.5%
FY2024Dec 31, 2024$370.90M+12.1%
FY2023Dec 31, 2023$331.00M+128.9%
FY2022Dec 31, 2022$144.60M-31.7%
FY2021Dec 31, 2021$211.60M+369.6%
FY2020Dec 31, 2020$45.06M+15.8%
FY2018Jun 30, 2018$38.93M+128.3%
FY2017Jun 30, 2017$17.05M-41.5%
FY2016Jun 30, 2016$29.14M+1.6%
FY2015Jun 30, 2015$28.69M+56.9%
FY2014Jun 30, 2014$18.28M+77.9%
FY2013Jun 30, 2013$10.27M-29.5%
FY2012Jun 30, 2012$14.57M-39.6%
FY2011Jun 30, 2011$24.13M+55.5%
FY2010Jun 30, 2010$15.51M+124.9%
FY2009Jun 30, 2009$6.90M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$180.50M-29.4%
Q1 FY2026CQ1 2026Mar 31, 2026$222.50M-30.1%
Q4 FY2025CQ4 2025Dec 31, 2025$306.10M-17.5%
Q3 FY2025CQ3 2025Sep 30, 2025$204.00M-19.6%
Q2 FY2025CQ2 2025Jun 30, 2025$255.70M-8.7%
Q1 FY2025CQ1 2025Mar 31, 2025$318.20M+6.3%
Q4 FY2024CQ4 2024Dec 31, 2024$370.90M+12.1%
Q3 FY2024CQ3 2024Sep 30, 2024$253.80M+86.6%
Q2 FY2024CQ2 2024Jun 30, 2024$280.20M+96.6%
Q1 FY2024CQ1 2024Mar 31, 2024$299.30M+144.3%
Q4 FY2023CQ4 2023Dec 31, 2023$331.00M+128.9%
Q3 FY2023CQ3 2023Sep 30, 2023$136.00M-13.5%
Q2 FY2023CQ2 2023Jun 30, 2023$142.50M-16.8%
Q1 FY2023CQ1 2023Mar 31, 2023$122.50M-35.8%
Q4 FY2022CQ4 2022Dec 31, 2022$144.60M-31.7%
Q3 FY2022CQ3 2022Sep 30, 2022$157.30M+31.2%
Q2 FY2022CQ2 2022Jun 30, 2022$171.20M+34.0%
Q1 FY2022CQ1 2022Mar 31, 2022$190.80M+37.5%
Q4 FY2021CQ4 2021Dec 31, 2021$211.60M+369.6%
Q3 FY2021CQ3 2021Sep 30, 2021$119.86M+315.1%
Q2 FY2021CQ2 2021Jun 30, 2021$127.78M+456.4%
Q1 FY2021CQ1 2021Mar 31, 2021$138.73M+424.5%
Q4 FY2020CQ4 2020Dec 31, 2020$45.06M+15.8%
Q3 FY2020CQ3 2020Sep 30, 2020$28.88M+75.0%
Q2 FY2020CQ2 2020Jun 30, 2020$22.96M+76.3%
Q1 FY2020CQ1 2020Mar 31, 2020$26.45M+120.7%
Q4 FY2018CQ2 2018Jun 30, 2018$38.93M+128.3%
Q3 FY2018CQ1 2018Mar 31, 2018$16.50M+7.3%
Q2 FY2018CQ4 2017Dec 31, 2017$13.03M-25.7%
Q1 FY2018CQ3 2017Sep 30, 2017$11.98M-46.9%
Q4 FY2017CQ2 2017Jun 30, 2017$17.05M-41.5%
Q3 FY2017CQ1 2017Mar 31, 2017$15.37M-53.8%
Q2 FY2017CQ4 2016Dec 31, 2016$17.53M-16.9%
Q1 FY2017CQ3 2016Sep 30, 2016$22.55M-6.1%
Q4 FY2016CQ2 2016Jun 30, 2016$29.14M+1.6%
Q3 FY2016CQ1 2016Mar 31, 2016$33.27M+5.1%
Q2 FY2016CQ4 2015Dec 31, 2015$21.09M–
Q1 FY2016CQ3 2015Sep 30, 2015$24.01M–
Q4 FY2015CQ2 2015Jun 30, 2015$28.69M–
Q3 FY2015CQ1 2015Mar 31, 2015$31.66M–

More EyePoint figures

See a number that looks wrong?